People On The Move: Appointments At Reckitt, Genomma Lab, Alliance Pharma

A round-up of the latest moves in the consumer health market: Reckitt has appointed former Sky chief exec Jeremy Darroch to its board; Genomma Lab is promoting COO Marco Sparvieri to the role of CEO; and Alliance Pharma has announced CEO Peter Butterfield is taking a short period of absence from the company.

Hired
• Source: Alamy

Reckitt has appointed Jeremy Darroch, former CEO of broadcaster Sky PLC, to its board of directors with immediate effect.

Darroch will serve as a senior independent non-executive director and as a member of the nomination and remuneration committees.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from HBW Insight

Questions For FDA On OTC Switches, Alternative Tests And Budget Cuts At OMUFA Hearing

 

Texas Democrat Lizzie Fletcher didn’t pose questions for witnesses at House Health Subcommittee hearing but used her floor time to question whether Congress will keep federal agencies afloat. “I have real concerns that even if we reauthorize these programs, we won't have the funding or the staff to

US FDA: No Replacement Yet For Animal Methods In Testing Systemic Effects Of Sunscreens

 
• By 

While FDA fully supports the recent roadmap to reduce and eliminate animal testing, animal tests are still necessary for assessing systemic effects, says Jacqueline Corrigan-Curay, acting director for CDER, during a House Energy and Commerce Health Subcommittee hearing.

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

 
• By 

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.